<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02740517</url>
  </required_header>
  <id_info>
    <org_study_id>D22105-115</org_study_id>
    <nct_id>NCT02740517</nct_id>
  </id_info>
  <brief_title>Usability Evaluation - Reassure Respiration Rate Device: Home User Study</brief_title>
  <official_title>Reassure Respiration Rate Device: Home User Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ResMed</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ResMed</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a usability evaluation of the Reassure device. The device is a non-contact device&#xD;
      which passively monitors breathing.&#xD;
&#xD;
      The purpose of this usability evaluation is to understand any issues that the intended user&#xD;
      population have while using the device unsupervised in the home and to determine if the&#xD;
      device can collect data that is of sufficient quality to be successfully analysed for&#xD;
      respiration rate.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the set of Reassure Home User Trials is to understand any usability issues that&#xD;
      users have while using the Reassure non contact monitor in their home environment.&#xD;
&#xD;
      Other objectives:&#xD;
&#xD;
        -  To gather useful feedback on the user interface and suggestions for its improvement.&#xD;
&#xD;
        -  To gather information on the device stability in the more variable conditions of the&#xD;
           home user environment.&#xD;
&#xD;
        -  To gather data in order to demonstrate compliance with IEC62366, and thus IEC60601-1&#xD;
&#xD;
      The users had the device for a minimum of 10 nights, to confirm if the device could be used&#xD;
      for an extended period and the likely compliance rates of users&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">November 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Nights' Data That Were Successfully Recorded</measure>
    <time_frame>At least 10 nights</time_frame>
    <description>The definitions utilised to determine the patient's success or otherwise at making a recording of their sleep respiration data are:&#xD;
• That 67% of the duration of the recording has to be of sufficient quality for the respiration rate algorithms to be able to discern a respiration rate.&#xD;
AND&#xD;
• The duration of analysable data is to be at least 2 hours.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of Recordings With Successful First Time Transmission</measure>
    <time_frame>For at least 10 nights of recordings</time_frame>
    <description>Percentage of the recordings that were successfully transmitted from the home location to the central database on the day of the recording</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">48</enrollment>
  <condition>Ease of Use</condition>
  <arm_group>
    <arm_group_label>HUT1</arm_group_label>
    <description>First phase of the home user trial. 19 users, 12 who were part of a couple and 7 who were single.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HUT2</arm_group_label>
    <description>Second phase of home user trial, testing improvements to the device user interface as a result of the experience from HUT1. Total 11 users.&#xD;
Main change to device was a simpler set of displays and button-sequence on a 24 hour period.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HUT3</arm_group_label>
    <description>Third phase of home user trial, testing the final improvements to the device. A total of 18 users, 16 of which who were part of a couple and 2 who were single.&#xD;
Main change was the introduction of a scheduled recording option, making the device totally automatic in routine use.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Up to 60 volunteers, all naïve to the device. The majority of the volunteers to be &gt;65&#xD;
        years old, to represent the likely user profile: person with a set of chronic diseases, and&#xD;
        not necessarily technically adept&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  volunteer, no previous exposure to the device&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  restless leg syndrome or other conditions giving to uncontrolled movements whilst&#xD;
             asleep&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul Phillips, MA, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>ResMed Sensor Technologies Ltd</affiliation>
  </overall_official>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 12, 2016</study_first_submitted>
  <study_first_submitted_qc>April 12, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 15, 2016</study_first_posted>
  <results_first_submitted>April 25, 2016</results_first_submitted>
  <results_first_submitted_qc>April 14, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">May 7, 2021</results_first_posted>
  <last_update_submitted>April 14, 2021</last_update_submitted>
  <last_update_submitted_qc>April 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Trial to validate the user features of the new medical device. Trial registered with ClinicalTrials.gov only because it involves human volunteers. No plans to publish</ipd_description>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Devices used in the subjects' own homes to monitor their respiration rates whilst asleep in their own beds. Subjects all naïve to the device. A mix of couples and single subjects used. The subjects are predominately senior citizens to replicate the most likely user of the device</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Home User Trial Phase 1 (HUT1)</title>
          <description>First phase of the home user trial.</description>
        </group>
        <group group_id="P2">
          <title>Home User Trial Phase 2 (HUT2)</title>
          <description>Second phase of home user trial, testing improvements to the device user interface as a result of the experience from HUT1.</description>
        </group>
        <group group_id="P3">
          <title>Home User Trial Phase 3 (HUT3)</title>
          <description>Third phase of home user trial, testing the final improvements to the device.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
                <participants group_id="P2" count="11"/>
                <participants group_id="P3" count="18"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="19"/>
                <participants group_id="P2" count="11"/>
                <participants group_id="P3" count="18"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Home User Trial Phase 1 (HUT1)</title>
          <description>First phase of the home user trial.</description>
        </group>
        <group group_id="B2">
          <title>Home User Trial Phase 2 (HUT2)</title>
          <description>Second phase of home user trial, testing improvements to the device user interface as a result of the experience from HUT1.</description>
        </group>
        <group group_id="B3">
          <title>Home User Trial Phase 3 (HUT3)</title>
          <description>Third phase of home user trial, testing the final improvements to the device.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="19"/>
            <count group_id="B2" value="11"/>
            <count group_id="B3" value="18"/>
            <count group_id="B4" value="48"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex/Gender, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="18"/>
                    <measurement group_id="B4" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Ireland</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="18"/>
                    <measurement group_id="B4" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Part of a Couple</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="16"/>
                    <measurement group_id="B4" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Single</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Nights' Data That Were Successfully Recorded</title>
        <description>The definitions utilised to determine the patient's success or otherwise at making a recording of their sleep respiration data are:&#xD;
• That 67% of the duration of the recording has to be of sufficient quality for the respiration rate algorithms to be able to discern a respiration rate.&#xD;
AND&#xD;
• The duration of analysable data is to be at least 2 hours.</description>
        <time_frame>At least 10 nights</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Home User Trial Phase 1 (HUT1)</title>
            <description>First phase of the home user trial.</description>
          </group>
          <group group_id="O2">
            <title>Home User Trial Phase 2 (HUT2)</title>
            <description>Second phase of home user trial, testing improvements to the device user interface as a result of the experience from HUT1.</description>
          </group>
          <group group_id="O3">
            <title>Home User Trial Phase 3 (HUT3)</title>
            <description>Third phase of home user trial, testing the final improvements to the device.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Nights' Data That Were Successfully Recorded</title>
          <description>The definitions utilised to determine the patient's success or otherwise at making a recording of their sleep respiration data are:&#xD;
• That 67% of the duration of the recording has to be of sufficient quality for the respiration rate algorithms to be able to discern a respiration rate.&#xD;
AND&#xD;
• The duration of analysable data is to be at least 2 hours.</description>
          <units>percentage of nights' data</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="11"/>
                <count group_id="O3" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79"/>
                    <measurement group_id="O2" value="86"/>
                    <measurement group_id="O3" value="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Recordings With Successful First Time Transmission</title>
        <description>Percentage of the recordings that were successfully transmitted from the home location to the central database on the day of the recording</description>
        <time_frame>For at least 10 nights of recordings</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Home User Trial Phase 1 (HUT1)</title>
            <description>First phase of the home user trial.</description>
          </group>
          <group group_id="O2">
            <title>Home User Trial Phase 2 (HUT2)</title>
            <description>Second phase of home user trial, testing improvements to the device user interface as a result of the experience from HUT1.</description>
          </group>
          <group group_id="O3">
            <title>Home User Trial Phase 3 (HUT3)</title>
            <description>Third phase of home user trial, testing the final improvements to the device.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Recordings With Successful First Time Transmission</title>
          <description>Percentage of the recordings that were successfully transmitted from the home location to the central database on the day of the recording</description>
          <units>percentage of first time transmissions</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="11"/>
                <count group_id="O3" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49"/>
                    <measurement group_id="O2" value="76.7"/>
                    <measurement group_id="O3" value="96.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>10 days during which the device was being used in the home environment</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Home User Trial Phase 1 (HUT1)</title>
          <description>First phase of the home user trial.</description>
        </group>
        <group group_id="E2">
          <title>Home User Trial Phase 2 (HUT2)</title>
          <description>Second phase of home user trial, testing improvements to the device user interface as a result of the experience from HUT1.</description>
        </group>
        <group group_id="E3">
          <title>Home User Trial Phase 3 (HUT3)</title>
          <description>Third phase of home user trial, testing the final improvements to the device.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="18"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Paul Phillips</name_or_title>
      <organization>ResMed</organization>
      <phone>+44 7789633508</phone>
      <email>paul.phillips@resmed.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

